Predominance of Early Endometrial Cancers After Long-term Estrogen Use

JAMA: The Journal of the American Medical Association

Volumn 244, Issue 21, 1980, Pages 2419-2422

  Hulka, Barbara S ^a   Kaufman, David G ^a   Fowler, Wesley C ^a   Grimson, Roger C ^a   Greenberg, Bernard G ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN DERIVATIVE;

ADVERSE DRUG REACTION; CARCINOGENESIS; DOSE RESPONSE; DRUG RESPONSE; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; FEMALE GENITAL SYSTEM; INTRAMUSCULAR DRUG ADMINISTRATION; LONG TERM CARE; ORAL DRUG ADMINISTRATION; THERAPY;

ADENOCARCINOMA; ADMINISTRATION, ORAL; ESTROGENS; FEMALE; HUMANS; MENOPAUSE; METHODS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RISK; TIME FACTORS; UTERINE NEOPLASMS;

EID: 0019216902     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1980.03310210021018     Document Type: Article

References (17)

1. Antunes CM, Stolley PD, Rosenshein NB, et al: Endometrial cancer and estrogen use. N Engl J Med 1979;300:9-13.
2. Mack TM, Pike MC, Henderson BE, et al: Estrogens and endometrial cancer in a retirement community. N Engl J Med 1976;294:1262-1267.
3. Hulka BS, Fowler WC, Kaufman DG, et al: Estrogen and endometrial cancer: Cases and two control groups from North Carolina. Am J Obstet Gynecol 1980;137:92-101.
4. Breslow N, Powers W: Are there two logistic regressions for retrospective studies? Biometrics 1978;34:100-105.
5. Fleiss JL: Statistical Methods for Rates and Proportions. New York, John Wiley & Sons Inc, 1973.
6. Weiss NS, Szekely DR, English DR, et al: Endometrial cancer in relation to patterns of menopausal estrogen use. JAMA 1979;242:261-264.
7. McDonald TW, Annegers JF, O'Fallon WM, et al: Exogenous estrogen and endometrial carcinoma: Case-control and incidence study. Am J Obstet Gynecol 1977;127:572-580.
8. Siiteri PK, Schwarz BE, MacDonald PC: Estrogen receptors and the estrone hypothesis in relation to endometrial and breast cancer. Gynecol Oncol 1974;2:228-238.
9. Yen SSC, Martin PL, Burnier AM, et al: Circulating estradiol, estrone and gonadotropin levels following the administration of orally active 17β-estradiol in postmenopausal women. J Clin Endocrinol Metab 1975;40:518-521.
10. Lind T, Cameron EHD, Hunter WM: Serum prolactin, gonadotrophin and oestrogen levels in women receiving hormone replacement therapy. Br J Obstet Gynecol 1978;85:138-141.
11. Siiteri PK, MacDonald PC: Role of extraglandular estrogen in human endocrinology, in Geiger S, Astwood E, Greep R (eds): Handbook of Physiology. Washington, DC, American Physiology Society, 1973, vol 2, chap 28, section 7.
12. Tseng L, Gurpide E: Effect of estrone and progesterone on the nuclear uptake of estradiol by slices of human endometrium. Endocrinology 1973;93:245-248.
13. Lipsett MB: Estrogen use and cancer risk. JAMA 1977;237:1112-1115.
14. Thom MH, White PJ, Williams RM, et al: Prevention and treatment of endometrial disease in climacteric women receiving oestrogen therapy. Lancet 1979;2:455-457.
15. Gambrell RD: Estrogens, progestogens and endometrial cancer. J Reprod Med 1977; 18:301-306.
16. Malkasian GD: Carcinoma of the endometrium: Effect of stage and grade of survival. Cancer 1978;41:996-1001.
17. Underwood PB, Miller MC, Kreutner A, et al: Endometrial carcinoma: The effect of estrogens. Gynecol Oncol 1979;8:60-73.